Harikumar Kaleeckal G, Potter Ross M, Patil Achyut, Echeveste Valerie, Miller Laurence J
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 13400 E. Shea Blvd., Scottsdale, AZ 85259, USA.
Lipids. 2013 Mar;48(3):231-44. doi: 10.1007/s11745-012-3744-4. Epub 2013 Jan 11.
The lipid microenvironment of membrane proteins can affect their structure, function, and regulation. We recently described differential effects of acute modification of membrane cholesterol on the function of type 1 and 2 cholecystokinin (CCK) receptors. We now explore the regulatory impact of chronic cholesterol modification on these receptors using novel receptor-bearing cell lines with elevated membrane cholesterol. Stable CCK1R and CCK2R expression was established in clonal lines of 25RA cells having gain-of-function in SCAP [sterol regulatory element binding protein (SREBP) cleavage-activating protein] and SRD15 cells having deficiencies in Insig-1 and Insig-2 enzymes affecting HMG CoA reductase and SREBP. Increased cholesterol in the plasma membrane of these cells was directly demonstrated, and receptor binding and signaling characteristics were shown to reflect predicted effects on receptor function. In both environments, both types of CCK receptors were internalized and recycled normally in response to agonist occupation. No differences in receptor distribution within the membrane were appreciated at the light microscopic level in these CHO-derived cell lines. Fluorescence anisotropy was studied for these receptors occupied by fluorescent agonist and antagonist, as well as when tagged with YFP. These studies demonstrated increased anisotropy of the agonist ligand occupying the active state of the CCK1R in a cholesterol-enriched environment, mimicking fluorescence of the uncoupled, inactive state of this receptor, while there was no effect of increasing cholesterol on fluorescence at the CCK2R. These cell lines should be quite useful for examining the functional characteristics of potential drugs that might be used in an abnormal lipid environment.
膜蛋白的脂质微环境会影响其结构、功能和调节。我们最近描述了膜胆固醇急性修饰对1型和2型胆囊收缩素(CCK)受体功能的不同影响。现在,我们使用具有升高膜胆固醇的新型受体携带细胞系,探索慢性胆固醇修饰对这些受体的调节作用。在25RA细胞的克隆系中建立了稳定的CCK1R和CCK2R表达,这些细胞在SCAP [固醇调节元件结合蛋白(SREBP)裂解激活蛋白]中具有功能获得,而SRD15细胞在影响HMG CoA还原酶和SREBP的Insig-1和Insig-2酶中存在缺陷。直接证明了这些细胞的质膜中胆固醇增加,并且受体结合和信号特征显示反映了对受体功能的预测影响。在这两种环境中,两种类型的CCK受体在激动剂占据后均正常内化和再循环。在这些CHO衍生的细胞系中,在光学显微镜水平上未观察到膜内受体分布的差异。研究了荧光激动剂和拮抗剂占据这些受体时以及用YFP标记时的荧光各向异性。这些研究表明,在富含胆固醇的环境中,占据CCK1R活性状态的激动剂配体的各向异性增加,模拟了该受体未偶联、无活性状态的荧光,而胆固醇增加对CCK2R的荧光没有影响。这些细胞系对于检查可能在异常脂质环境中使用的潜在药物的功能特性应该非常有用。